VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
Public ClinicalTrials.gov record NCT05370885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2 study to evaluate the safety, efficacy, and microbiota changes of VE202 in patients with mild to moderate ulcerative colitis (UC).
Study identification
- NCT ID
- NCT05370885
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 114 participants
Conditions and interventions
Conditions
Interventions
- VE202 Biological
- Vancomycin Oral Capsule Drug
- VE202 Placebo Other
- Vancomycin Placebo Other
Biological · Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 7, 2023
- Primary completion
- Aug 28, 2025
- Completion
- Aug 28, 2025
- Last update posted
- Dec 16, 2025
2023 – 2025
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GI Pros Research | Naples | Florida | 34102 | — |
| Revival Clinical Research | Orlando | Florida | 32807 | — |
| Atlanta Center for Gastroenterology, P.C. & Atlanta Endoscopy Center, LTD | Decatur | Georgia | 30033-6146 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| NYU IBD Center | New York | New York | 10016 | — |
| Cornell University Weill Cornell Medicine New York Presbyterian Hospital | New York | New York | 10021 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Gastroenterology Research of America, LLC | San Antonio | Texas | 78229 | — |
| University of Utah Hospitals and Clinics | Salt Lake City | Utah | 84132 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05370885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2025 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05370885 live on ClinicalTrials.gov.